CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}

Cushman & Wakefield Arranges $4.5M Sale of Owner Occupancy Redevelopment Site in Revere

Jayden Lapin-Tatman • 3/31/2022

Revere, MA – Cushman & Wakefield announced today that the real estate services firm has arranged the sale of 133 Salem Street, the former West Revere Health Center, in Revere.  The 140-bed former nursing home sold for $4,500,000, equating to $76 per square foot. 

Cushman & Wakefield’s Bruce Lusa, Chris Sower, Jon Bryant, John Flaherty, Kevin Jones, Julie Regan and Mary VanNatta represented the seller, Capital Funding Group, Inc., in the transaction.  The property was acquired by Broadway Capital Inc., a full-service real estate firm with headquarters in Chelsea, Massachusetts. Broadway Capital intends to redevelop the property into owner occupancy housing.  
“133 Salem Street is an exceptional residential location and redevelopment opportunity,” said Lusa.  “The strong demand for housing in this neighborhood makes this an exciting acquisition for Broadway Capital, which has a track record of success redeveloping similar buildings into high quality housing.” 

133 Salem Street is currently a three-story, 59,000 square foot former skilled nursing facility with a 140-bed capacity. The building features 10-foot ceilings, abundant windows and a flexible footprint well-suited for housing units. 

“The 133 Salem Street project is an exciting opportunity for Revere homebuyers,” added Mayor Brian Arrigo. “Partnerships with private investors have a profound impact on our city’s ability to grow responsibly while addressing the needs of our residents. I’m thankful for those who have worked on this project so far and I’m looking forward to seeing it progress.” 

The property is located five miles north of downtown Boston. The site is proximate to the Wonderland, Revere Beach and Beachmont MBTA Blue Line stations and offers immediate access to US Route 1 North. 

“The regional housing inventory is very low and the City of Revere is no exception. This vibrant community is a desirable place to live and we want to support the city’s strategic plan to address the shortage,” said Mike Vienneau, Managing Director of Broadway Capital.

“We see a tremendous amount of opportunity to develop owner-occupied housing in Revere and in surrounding communities. At a starting price point in the high $200s, these condominiums will give first-time home buyers an opportunity to purchase their own homes in a very competitive real estate market.”   
About Broadway Capital 
Broadway Capital is a privately held real estate firm located in Chelsea, MA with a focus on mid-level multi-family properties. The company’s strategy is to seek out and acquire under-performing real estate assets and reposition via rent adjustments, capital improvements and cost control measures. The firm is both an equity and managing partner in all the investments it sponsors, offering the following services through its subsidiaries: Property Management, Property Maintenance, Project Management and Real Estate Development. To learn more, visit www.broadwaycapital.com 

About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2023, the firm reported revenue of $9.5 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), sustainability and more. For additional information, visit www.cushmanwakefield.com.

CAN'T FIND WHAT YOU'RE LOOKING FOR?

Get in touch with one of our professionals.

With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on  Cookies

More Options
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS